Correspondence: Flu researchers pause for thought
The authors of two H5N1-related papers, to be published in Nature and Science respectively, today announce in those journals their decision to call a voluntary 60-day pause on research involving highly pathogenic avian influenza H5N1 viruses leading to the generation of viruses that are more transmissible in mammals. The statement by Yoshihiro Kawaoka, Ron Fouchier and their colleagues, and co-signed by influenza researchers from around the world, outlines how experiments with live H5N1 or H5 HA reassortant viruses — already shown to be transmissible in ferrets — will halt during this time.
This decision has been made in acknowledgment of the fact that the benefits of this research need to be clearly explained, and organizations and governments around the world need time to discuss the best solutions for opportunities and challenges that arise from this work. The scientists recognize that despite the positive public-health benefits that the currently unpublished work seeks to provide, a perceived fear that the ferret-transmissible H5 HA viruses may escape from the laboratories has generated intense debate in the media on the benefits and potential harm of this research. The researchers wish to reassure the public that these experiments have been conducted in such a way that minimizes any risk of accidental release, and they say that whether ferret-adapted influenza viruses can be transmitted from human to human cannot be tested.
Elsewhere, in a Nature News story, Declan Butler explores the implications of today’s announcement.
For more information please contact:
Yoshihiro Kawaoka (University of Tokyo, Japan; and University of Wisconsin-Madison, WI, USA)
Email: [email protected]
Please note Yoshihiro Kawaoka is travelling and email is the best contact for him
Alternative contact;
Ruth Francis, Rachel Twinn or Neda Afsarmanesh in the Nature Press Office
Email: [email protected], [email protected], [email protected]
Special Note:
Please refer also to the Science Press Package on EurekAlert!, http://www.eurekalert.org/jrnls/sci/ or contact +1 202 326 6421, [email protected].
----------------------------------------------------------------
About Nature Publishing Group (NPG):
Nature Publishing Group (NPG) is a publisher of high impact scientific and medical information in print and online. NPG publishes journals, online databases and services across the life, physical, chemical and applied sciences and clinical medicine.
Focusing on the needs of scientists, Nature (founded in 1869) is the leading weekly, international scientific journal. In addition, for this audience, NPG publishes a range of Nature research journals and Nature Reviews journals, plus a range of prestigious academic journals including society-owned publications. Online, nature.com provides over 5 million visitors per month with access to NPG publications and online databases and services, including Nature News and NatureJobs plus access to Nature Network and Nature Education’s Scitable.com.
Scientific American is at the heart of NPG’s newly-formed consumer media division, meeting the needs of the general public. Founded in 1845, Scientific American is the oldest continuously published magazine in the US and the leading authoritative publication for science in the general media. Together with scientificamerican.com and 15 local language editions around the world it reaches over 3 million consumers and scientists. Other titles include Scientific American Mind and Spektrum der Wissenschaft in Germany.
Throughout all its businesses NPG is dedicated to serving the scientific and medical communities and the wider scientifically interested general public. Part of Macmillan Publishers Limited, NPG is a global company with principal offices in London, New York and Tokyo, and offices in cities worldwide including Boston, Buenos Aires, Delhi, Hong Kong, Madrid, Barcelona, Munich, Heidelberg, Basingstoke, Melbourne, Paris, San Francisco, Seoul and Washington DC. For more information, please go to www.nature.com.
